These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 12137609)
21. Should expedited partner treatment for women with Trichomonas vaginalis be recommended? Kissinger P Sex Transm Dis; 2010 Jun; 37(6):397-8. PubMed ID: 20453719 [No Abstract] [Full Text] [Related]
22. Trichomoniasis and adverse birth outcomes: a systematic review and meta-analysis. Van Gerwen OT; Craig-Kuhn MC; Jones AT; Schroeder JA; Deaver J; Buekens P; Kissinger PJ; Muzny CA BJOG; 2021 Nov; 128(12):1907-1915. PubMed ID: 34036690 [TBL] [Abstract][Full Text] [Related]
29. Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. McGregor JA; French JI; Parker R; Draper D; Patterson E; Jones W; Thorsgard K; McFee J Am J Obstet Gynecol; 1995 Jul; 173(1):157-67. PubMed ID: 7631673 [TBL] [Abstract][Full Text] [Related]
30. Management of recalcitrant Trichomonas vaginalis in pregnancy: a case report. Tayal S Int J STD AIDS; 2016 Feb; 27(2):147-8. PubMed ID: 25829518 [TBL] [Abstract][Full Text] [Related]
31. What have we learned about vaginal infections and preterm birth? Carey JC; Klebanoff MA; Semin Perinatol; 2003 Jun; 27(3):212-6. PubMed ID: 12889588 [TBL] [Abstract][Full Text] [Related]
32. [Significance of the treatment of trichomoniasis in gynecology and obstetrics]. Zawadzki J; Starzyk J Wiad Parazytol; 1969; 15(3):473-5. PubMed ID: 5388940 [No Abstract] [Full Text] [Related]
33. [Trichomoniasis in women. A personal method of treatment]. Senra A Hospital (Rio J); 1969 Jul; 76(1):245-83. PubMed ID: 5307530 [No Abstract] [Full Text] [Related]
34. Drug repositioning for novel antitrichomonas from known antiprotozoan drugs using hierarchical screening. Meneses-Marcel A; Marrero-Ponce Y; Ibáñez-Escribano A; Gómez-Barrio A; Escario JA; Barigye SJ; Terán E; García-Jacas CR; Machado-Tugores Y; Nogal-Ruiz JJ; Arán-Redó VJ Future Med Chem; 2018 Apr; 10(8):863-878. PubMed ID: 29589477 [TBL] [Abstract][Full Text] [Related]
35. Metronidazole for the treatment of vaginal infections. Sobel R; Sobel JD Expert Opin Pharmacother; 2015 May; 16(7):1109-15. PubMed ID: 25887246 [TBL] [Abstract][Full Text] [Related]
37. Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure. Bosserman EA; Helms DJ; Mosure DJ; Secor WE; Workowski KA Sex Transm Dis; 2011 Oct; 38(10):983-7. PubMed ID: 21934577 [TBL] [Abstract][Full Text] [Related]
38. [Clinical evaluation of medicines active against trichomoniasis vaginalis in a double-blind study]. Heiss H Wien Med Wochenschr; 1971 Nov; 121(46):832-4. PubMed ID: 4945029 [No Abstract] [Full Text] [Related]
39. Secnidazole for Trichomoniasis in Women and Men. Muzny CA; Van Gerwen OT Sex Med Rev; 2022 Apr; 10(2):255-262. PubMed ID: 35153156 [TBL] [Abstract][Full Text] [Related]
40. Trichomoniasis in pregnancy and mental retardation in children. Mann JR; McDermott S; Barnes TL; Hardin J; Bao H; Zhou L Ann Epidemiol; 2009 Dec; 19(12):891-9. PubMed ID: 19944351 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]